Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Gastroenterology. 2010 Dec 24;140(4):1174–1181. doi: 10.1053/j.gastro.2010.12.035

Figure 2.

Figure 2

Kaplan-Meier survival curves demonstrating the effect of CIMP status on survival according to 5-FU based chemotherapy treatment. In patients with CIMP-negative tumors (panel A), adjuvant chemotherapy clearly provides a survival benefit with a higher probability of disease-free survival (DFS). In patients with CIMP-positive tumors (panel B), the use of 5-FU based adjuvant chemotherapy does not improve DFS. Vertical tick marks indicate censored events.